Immune responses to gut bacteria associated with time to diagnosis and clinical response to T cell–directed therapy for type 1 diabetes prevention

Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders

(2022) Amira Metwaly et al.   Nature Reviews Gastroenterology & Hepatology

Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study

(2022) Jeffrey P. Krischer et al.   DIABETES CARE

Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes

(2022) Charlotte K. Boughton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab for the treatment of multiple sclerosis: a review

(2021) Clara Grazia Chisari et al.   JOURNAL OF NEUROLOGY

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

(2021) Emily K. Sims et al.   Science Translational Medicine

Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation

(2021) Ivica Letunic et al.   NUCLEIC ACIDS RESEARCH

The Deterrence of Rapid Metabolic Decline within 3 Months after Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes

(2021) Emily K. Sims et al.   DIABETES

Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study

(2021) Maureen M. Leonard et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Preventing type 1 diabetes in childhood

(2021) Colin M. Dayan et al.   SCIENCE

Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut

(2021) Martin F. Laursen et al.   Nature Microbiology

A combined risk score enhances prediction of type 1 diabetes among susceptible children

(2020) Lauric A. Ferrat et al.   NATURE MEDICINE

Mucosal-associated invariant T cell alterations during the development of human type 1 diabetes

(2020) Ahmad M. Gazali et al.   DIABETOLOGIA

Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score

(2019) Suna Onengut-Gumuscu et al.   DIABETES CARE

Landmark analysis: A primer

(2019) Charity J. Morgan   JOURNAL OF NUCLEAR CARDIOLOGY

Challenges in the treatment of Rheumatoid Arthritis

(2019) Paola Conigliaro et al.   AUTOIMMUNITY REVIEWS

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

(2019) Kevan C. Herold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes

(2019) Chiara Sorini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Microbiome and type 1 diabetes

(2019) Heli Siljander et al.   EBioMedicine

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

(2019) Manuela Battaglia et al.   DIABETES CARE

Lactose drives Enterococcus expansion to promote graft-versus-host disease

(2019) C. K. Stein-Thoeringer et al.   SCIENCE

Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis

(2018) Ana Luisa Perdigoto et al.   DIABETOLOGIA

The human gut microbiome in early-onset type 1 diabetes from the TEDDY study

(2018) Tommi Vatanen et al.   NATURE

Temporal development of the gut microbiome in early childhood from the TEDDY study

(2018) Christopher J. Stewart et al.   NATURE

The challenge of modulating β-cell autoimmunity in type 1 diabetes

(2018) Mark A Atkinson et al.   Lancet Diabetes & Endocrinology

Autoreactive T cells in type 1 diabetes

(2017) Alberto Pugliese   JOURNAL OF CLINICAL INVESTIGATION

Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans

(2016) Tommi Vatanen et al.   CELL

Boosting in Cox regression: a comparison between the likelihood-based and the model-based approaches with focus on the R-packages CoxBoost and mboost

(2016) Riccardo De Bin   COMPUTATIONAL STATISTICS

Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes

(2016) Claudio Maffeis et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Young people with Type 1 diabetes of non-white ethnicity and lower socio-economic status have poorer glycaemic control in England and Wales

(2016) A. R. Khanolkar et al.   DIABETIC MEDICINE

Immune recognition and response to the intestinal microbiome in type 1 diabetes

(2016) Alexandra Paun et al.   JOURNAL OF AUTOIMMUNITY

The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes

(2015) Aleksandar D. Kostic et al.   Cell Host & Microbe

Changes in T-cell subsets identify responders to FcR-nonbinding anti-CD3 mAb (teplizumab) in patients with type 1 diabetes

(2015) James E. Tooley et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Immunogenetics of type 1 diabetes mellitus

(2015) Michael P. Morran et al.   MOLECULAR ASPECTS OF MEDICINE

JM: AnRPackage for the Joint Modelling of Longitudinal and Time-to-Event Data

(2015) Dimitris Rizopoulos   Journal of Statistical Software

Enterococcus faecalis from Healthy Infants Modulates Inflammation through MAPK Signaling Pathways

(2014) Shugui Wang et al.   PLoS One

Optimizing anti-TNF treatments in inflammatory bowel disease

(2013) Shomron Ben-Horin et al.   AUTOIMMUNITY REVIEWS

HLA Class II Genotyping of African American Type 1 Diabetic Patients Reveals Associations Unique to African Haplotypes

(2013) Janelle A. Noble et al.   DIABETES

Type 1 diabetes

(2013) Mark A Atkinson et al.   LANCET

Teplizumab Induces Human Gut-Tropic Regulatory Cells in Humanized Mice and Patients

(2012) F. Waldron-Lynch et al.   Science Translational Medicine

Genetics of the HLA Region in the Prediction of Type 1 Diabetes

(2011) Janelle A. Noble et al.   Current Diabetes Reports

Enterococcus faecalis Metalloprotease Compromises Epithelial Barrier and Contributes to Intestinal Inflammation

(2011) Natalie Steck et al.   GASTROENTEROLOGY

HLA-DQ haplotypes differ by ethnicity in patients with childhood-onset diabetes

(2011) Rebecca B Lipton et al.   PEDIATRIC DIABETES

Banting Lecture 2009: An Unfinished Journey: Molecular Pathogenesis to Prevention of Type 1A Diabetes

(2010) G. S. Eisenbarth   DIABETES

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

(2009) Kathleen Hawker et al.   ANNALS OF NEUROLOGY

HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk: Analysis of the Type 1 Diabetes Genetics Consortium Families

(2008) H. Erlich et al.   DIABETES

Ethnicity and social deprivation independently influence metabolic control in children with type 1 diabetes

(2008) P. J. Carter et al.   DIABETOLOGIA

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Enterococcus faecalis from newborn babies regulate endogenous PPAR  activity and IL-10 levels in colonic epithelial cells

(2008) A. Are et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Immortal Time Bias in Pharmacoepidemiology

(2007) S. Suissa   AMERICAN JOURNAL OF EPIDEMIOLOGY